These investigators have completed studies in Senegal that suggest that HIV-2 infection may be attenuated among untreated patients concurrently infected with HIV-2. They found that dually infected subjects had markedly lower mean plasma HIV-1 RNA levels, were 5.6 times more likely to have less than 400 HIV-1 RNA copies/mol, and had slower rates of CD4 count decline than were those with HIV-1 infection alone. In recent pilot studies, using and IFN-gamma ELISPOT assay to examine 18 HIV-1 and 9 dual HIV-1/2 injected subjects, lower plasma HIV-1 RNA levels were associated with the presence of Gag specific T cells with the ability to respond to HIV-2 Gag epitopes. Based on these findings, they hypothesize that these antigen-specific T cells provide a strong and stable immune defense against HIV-1 through MHC-restricted cytolytic T-cell activity, secretion of anti-viral cytokines and chemokines, and CD4+ T helper function. To test this hypothesis, they propose to: 1) confirm observations that the presence of HIV-2 Gag specific T cells enhances the host's ability to control HIV-2 infection and determine whether the ability to respond to other HIV-1 or HIV-2 epitopes (selected regions of nef, pol, env) provides additional control of HIV-1 infection. 2) Evaluate HIV-specific T-cell responses over time among those infected with HIV-1 alone and dually infected with both HIV-1 and HIV-2 in relationship to change in HIV-1 plasma viral load and CD4 count. 3) Determine the contribution of MHC-restricted class 1 CTL and release of anti-viral soluble mediators in observed control of HIV-1. 4) Delineate the contribution of HIV-2-specific CD4+ T helper cells in the control of HIV-1 infection. This study, which evaluates cellular immune responses in relation to viral load and CD4 count among untreated subjects who do and do not appear to be successfully controlling HIV-1 replication, offers the opportunity to define protective components of the host immune response to HIV. Identification of these responses may provide information relevant to future HIV vaccine development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI048470-03
Application #
6534299
Study Section
Special Emphasis Panel (ZRG1-AARR-6 (02))
Program Officer
Dieffenbach, Carl M
Project Start
2000-09-29
Project End
2005-05-31
Budget Start
2002-09-01
Budget End
2003-05-31
Support Year
3
Fiscal Year
2002
Total Cost
$460,683
Indirect Cost
Name
University of Washington
Department
Pathology
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Whitham, Hilary K; Hawes, Stephen E; Chu, Haitao et al. (2017) A Comparison of the Natural History of HPV Infection and Cervical Abnormalities among HIV-Positive and HIV-Negative Women in Senegal, Africa. Cancer Epidemiol Biomarkers Prev 26:886-894
Hanisch, Rachel A; Cherne, Stephen L; Sow, Papa Salif et al. (2014) Human papillomavirus type 16 viral load in relation to HIV infection, cervical neoplasia and cancer in Senegal. Cancer Epidemiol 38:369-75
Hanisch, R A; Sow, P S; Toure, M et al. (2013) Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa. J Clin Virol 58:696-702
Raugi, Dana N; Gottlieb, Geoffrey S; Sow, Papa S et al. (2013) HIV-1 outcompetes HIV-2 in dually infected Senegalese individuals with low CD4ýýý cell counts. AIDS 27:2441-50
Heitzinger, K; Sow, P S; Dia Badiane, N M et al. (2012) Trends of HIV-1, HIV-2 and dual infection in women attending outpatient clinics in Senegal, 1990-2009. Int J STD AIDS 23:710-6
Zheng, Natalie N; McElrath, M Juliana; Sow, Papa Salif et al. (2011) Association between peripheral ?? T-cell profile and disease progression in individuals infected with HIV-1 or HIV-2 in West Africa. J Acquir Immune Defic Syndr 57:92-100
Zheng, Natalie N; McElrath, M Juliana; Sow, Papa-Salif et al. (2007) Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection. J Virol 81:9061-71
Zheng, N N; Kiviat, N B; Sow, P S et al. (2004) Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal. J Virol 78:13934-42
Gottlieb, Geoffrey S; Sow, Papa Salif; Hawes, Stephen E et al. (2003) Molecular epidemiology of dual HIV-1/HIV-2 seropositive adults from Senegal, West Africa. AIDS Res Hum Retroviruses 19:575-84